Time to Sputum Culture Conversion and Treatment Outcomes Among Patients with Isoniazid-Resistant Tuberculosis in Atlanta, Georgia | Zendy

Marcos C. Schechter | Zendy; Destani Bizune | Zendy; Michelle Kagei | Zendy; Mamuka Machaidze | Zendy; David Holland | Zendy; Alawode Oladele | Zendy; Yun F. Wang | Zendy; Paulina A. Rebolledo | Zendy; Susan M. Ray | Zendy; Russell R. Kempker | Zendy

Open Access

Time to Sputum Culture Conversion and Treatment Outcomes Among Patients with Isoniazid-Resistant Tuberculosis in Atlanta, Georgia

Author(s) -

Marcos C. Schechter,

Destani Bizune,

Michelle Kagei,

Mamuka Machaidze,

David Holland,

Alawode Oladele,

Yun F. Wang,

Paulina A. Rebolledo,

Susan M. Ray,

Russell R. Kempker

Publication year - 2017

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/cix686

Subject(s) - isoniazid , medicine , ethambutol , tuberculosis , pyrazinamide , hazard ratio , sputum culture , culture conversion , sputum , drug resistance , regimen , rifampicin , multi drug resistant tuberculosis , surgery , confidence interval , mycobacterium tuberculosis , microbiology and biotechnology , pathology , biology

Although isoniazid-resistant tuberculosis is more common than multidrug-resistant tuberculosis, it has been much less studied. We examined the impact of isoniazid resistance and treatment regimen, including use of a fluoroquinolone, on clinical outcomes.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research